Suppr超能文献

铁死亡中线粒体的多方面调控

The Multifaceted Regulation of Mitochondria in Ferroptosis.

作者信息

Wu Hao, Wang Fengli, Ta Na, Zhang Ting, Gao Weihua

机构信息

State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.

Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

出版信息

Life (Basel). 2021 Mar 10;11(3):222. doi: 10.3390/life11030222.

Abstract

Ferroptosis is characterized as a novel form of regulated cell death, which is initiated by the lethal accumulation of lipid peroxidation catalyzed by cellular labile free iron. This iron driven cell death sharply differs from other well characterized forms of regulated cell death at morphological, genetic and biochemical levels. Increasing research has elaborated a high relevance between dysregulated ferroptosis and the pathogenesis of degenerative diseases and organs injury in human patients. Additionally, targeted induction of ferroptosis is considered as a potentially therapeutic design for the clinical intervention of other therapy-resistant cancers. It is well understood that mitochondria, the cellular powerhouse, determine several types of regulated cell death. Recently, compromised mitochondrial morphology and functionalities have been primarily formulated in ferroptosis. Several mitochondria associated proteins and metabolic processes have been elaborated to fine-tune ferroptotic program. Herein, we critically review the recent advances in this booming field, with focus on summarizing the multifaceted mitochondrial regulation of ferroptosis and providing a perspective on the potential biochemical basis. Finally, we are attempting to shed light on an integrative view on the possibility of mitochondria- and ferroptosis-targeting therapeutics as novel treatment designs for the intervention of ferroptosis related diseases.

摘要

铁死亡被认为是一种新型的程序性细胞死亡形式,它由细胞内不稳定游离铁催化的脂质过氧化的致命积累引发。这种铁驱动的细胞死亡在形态、遗传和生化水平上与其他已明确的程序性细胞死亡形式有显著差异。越来越多的研究表明,铁死亡失调与人类患者退行性疾病的发病机制和器官损伤高度相关。此外,靶向诱导铁死亡被认为是一种针对其他难治性癌症进行临床干预的潜在治疗策略。众所周知,作为细胞动力源的线粒体决定了几种程序性细胞死亡类型。最近,线粒体形态和功能受损主要被认为与铁死亡有关。一些与线粒体相关的蛋白质和代谢过程已被阐明可微调铁死亡程序。在此,我们批判性地回顾了这个蓬勃发展领域的最新进展,重点总结了铁死亡的多方面线粒体调控,并提供了潜在生化基础的观点。最后,我们试图阐明一种综合观点,即针对线粒体和铁死亡的治疗方法作为干预铁死亡相关疾病的新型治疗设计的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2a8/8001967/8404ebe471c5/life-11-00222-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验